Vivo Capital, LLC

Vivo Capital, LLC is a global healthcare investment firm founded in 1996, specializing in investments across venture capital, private equity, and public equity strategies. The firm manages approximately $5.3 billion in assets and has invested in over 430 public and private companies worldwide. Headquartered in Palo Alto, California, Vivo Capital also maintains offices in Beijing, Hong Kong, Shanghai, and Taipei.

The firm's investment focus spans biotechnology, pharmaceuticals, medical devices, and healthcare services, primarily targeting the U.S. and East Asia markets, particularly China. Vivo Capital employs a multi-pronged strategy, identifying and collaborating with companies developing and commercializing innovative healthcare products and technologies.

Vivo Capital has a strong track record of supporting companies that have achieved significant milestones, including regulatory approvals and acquisitions by major pharmaceutical companies. Notable investments include Sinovac Biotech, WuXi AppTec, Amyris, Angiotech Pharmaceuticals, and Precision BioSciences. The firm's team comprises professionals with backgrounds in medicine, science, and entrepreneurship, enabling effective navigation of the healthcare sector's complexities.